Nature2 天
BioViva’s CMV vector: a platform for better gene-therapy delivery
BioViva is building a gene-therapy platform using a cytomegalovirus (CMV) that can carry a genetic payload three times larger than the AAV. The company hopes to expand this to at least 10 times ...
生物通1 年
荧光蛋白AAV对照
100ul ￥960 24h ssAAV-retro-EA021-100 AAV-retro [EA021 ssAAV.CAG.EGFP.WPREs.SV40pA],≥1E+13 GC/mL,100ul ￥960 24h ssAAV1-EA041-100 AAV1 [EA041 ssAAV.CMV.EGFP.WPREs.SV40pA],≥1E+13 GC/mL,100ul ￥960 24h ...